{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,2]],"date-time":"2026-06-02T10:18:50Z","timestamp":1780395530908,"version":"3.54.1"},"reference-count":37,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2013,1,1]],"date-time":"2013-01-01T00:00:00Z","timestamp":1356998400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2013,1,1]],"date-time":"2013-01-01T00:00:00Z","timestamp":1356998400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"name":"Medical Research Fund of Tampere University Hospital"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Epilepsy Research"],"published-print":{"date-parts":[[2013,1]]},"DOI":"10.1016\/j.eplepsyres.2012.06.002","type":"journal-article","created":{"date-parts":[[2012,6,29]],"date-time":"2012-06-29T17:16:33Z","timestamp":1340990193000},"page":"54-61","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"title":["High concentration of immunoglobulin A is associated with temporal lobe epilepsy"],"prefix":"10.1016","volume":"103","author":[{"given":"Suvi","family":"Liimatainen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mahdi","family":"Fallah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elham","family":"Kharazmi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna-Maija","family":"Haapala","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jouko","family":"Isoj\u00e4rvi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jukka","family":"Peltola","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.eplepsyres.2012.06.002_bib0005","doi-asserted-by":"crossref","first-page":"922","DOI":"10.1111\/j.1528-1157.1996.tb00527.x","article-title":"Cryptogenic partial epilepsies with anti-GM1 antibodies: a new form of immune-mediated epilepsy?","volume":"37","author":"Bartolomei","year":"1996","journal-title":"Epilepsia"},{"key":"10.1016\/j.eplepsyres.2012.06.002_bib0010","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1111\/j.1528-1157.1990.tb05386.x","article-title":"Possible induction of systemic lupus erythematosus by valproate","volume":"31","author":"Bleck","year":"2009","journal-title":"Epilepsia"},{"key":"10.1016\/j.eplepsyres.2012.06.002_bib0015","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1046\/j.1442-200x.2001.01325.x","article-title":"Immunoglobulin subgroups in children with febrile seizures","volume":"43","author":"Caksen","year":"2001","journal-title":"Pediatr. Int."},{"key":"10.1016\/j.eplepsyres.2012.06.002_bib0020","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1046\/j.1365-2249.2003.02097.x","article-title":"Immunoglobulins in children with epilepsy: the Dutch Study of Epilepsy in Childhood","volume":"132","author":"Callenbach","year":"2003","journal-title":"Clin. Exp. Immunol."},{"key":"10.1016\/j.eplepsyres.2012.06.002_bib0025","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1111\/j.1528-1157.1989.tb05316.x","article-title":"Proposal for revised classification of epilepsies and epileptic syndromes","volume":"30","author":"Commission on Classification and Terminology of the International League Against Epilepsy","year":"1989","journal-title":"Epilepsia"},{"key":"10.1016\/j.eplepsyres.2012.06.002_bib0030","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/S0006-8993(02)03050-0","article-title":"Inflammatory reactions in human medial temporal lobe epilepsy with hippocampal sclerosis","volume":"952","author":"Crespel","year":"2002","journal-title":"Brain Res."},{"key":"10.1016\/j.eplepsyres.2012.06.002_bib0035","doi-asserted-by":"crossref","first-page":"4637","DOI":"10.4049\/jimmunol.169.8.4637","article-title":"MHC susceptibility genes to IgA deficiency are located in different regions on different HLA haplotypes","volume":"169","author":"De la Concha","year":"2002","journal-title":"J. Immunol."},{"key":"10.1016\/j.eplepsyres.2012.06.002_bib0040","doi-asserted-by":"crossref","first-page":"235","DOI":"10.2165\/00002018-199308030-00005","article-title":"Immunological adverse effects of anticonvulsants. What is their clinical relevance?","volume":"8","author":"De Ponti","year":"1993","journal-title":"Drug Saf."},{"key":"10.1016\/j.eplepsyres.2012.06.002_bib0045","doi-asserted-by":"crossref","first-page":"885","DOI":"10.2174\/156802607780636717","article-title":"Dual carbonic anhydrase \u2013 cyclooxygenase-2 inhibitors","volume":"7","author":"Dogn\u00e9","year":"2007","journal-title":"Curr. Top. Med. Chem."},{"key":"10.1016\/j.eplepsyres.2012.06.002_bib0050","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1111\/j.1600-0404.1988.tb03671.x","article-title":"Immunological studies in focal epilepsy","volume":"78","author":"Eeg-Olofsson","year":"1988","journal-title":"Acta Neurol. Scand."},{"key":"10.1016\/j.eplepsyres.2012.06.002_bib0055","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1016\/S0140-6736(76)91028-X","article-title":"IgA deficiency, epilepsy, and hydantoin medication","volume":"2","author":"Fontana","year":"1976","journal-title":"Lancet"},{"key":"10.1016\/j.eplepsyres.2012.06.002_bib0060","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1016\/0192-0561(82)90031-5","article-title":"HLA antigens in epileptic patients with drug-induced immunodeficiency","volume":"4","author":"Gilhus","year":"1982","journal-title":"Int. J. Immunopharmacol."},{"key":"10.1016\/j.eplepsyres.2012.06.002_bib0065","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1002\/art.1780370418","article-title":"Association between antiphospholipid antibodies and epilepsy in patients with systemic lupus erythematosus","volume":"37","author":"Herranz","year":"1994","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.eplepsyres.2012.06.002_bib0070","doi-asserted-by":"crossref","first-page":"350","DOI":"10.2165\/00002018-199106050-00005","article-title":"Systemic lupus erythematosus (SLE)-like syndromes associated with carbamazepine therapy","volume":"6","author":"Jain","year":"1991","journal-title":"Drug Saf."},{"key":"10.1016\/j.eplepsyres.2012.06.002_bib0075","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.1111\/j.1528-1167.2009.02397.x","article-title":"Definition of drug resistant epilepsy: consensus proposal by the ad hoc Task Force of the ILAE Commission on Therapeutic Strategies","volume":"51","author":"Kwan","year":"2010","journal-title":"Epilepsia"},{"key":"10.1016\/j.eplepsyres.2012.06.002_bib0080","doi-asserted-by":"crossref","first-page":"796","DOI":"10.1007\/s00415-009-5021-x","article-title":"Interleukin-6 levels are increased in temporal lobe epilepsy but not in extra-temporal lobe epilepsy","volume":"256","author":"Liimatainen","year":"2009","journal-title":"J. Neurol."},{"key":"10.1016\/j.eplepsyres.2012.06.002_bib0085","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1111\/j.1468-1331.2008.02373.x","article-title":"The high prevalence of antiphospholipid antibodies in refractory focal epilepsy is related to recurrent seizures","volume":"16","author":"Liimatainen","year":"2009","journal-title":"Eur. J. Neurol."},{"key":"10.1016\/j.eplepsyres.2012.06.002_bib0090","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1111\/j.1528-1167.2009.02325.x","article-title":"The clinical significance of glutamic acid decarboxylase antibodies in chronic epilepsy","volume":"51","author":"Liimatainen","year":"2010","journal-title":"Epilepsia"},{"key":"10.1016\/j.eplepsyres.2012.06.002_bib0095","doi-asserted-by":"crossref","DOI":"10.1016\/j.eplepsyres.2011.02.003","article-title":"Increased indoleamine 2,3-dioxygenase (IDO) activity in idiopathic generalized epilepsy","author":"Liimatainen","year":"2011","journal-title":"Epilepsy Res."},{"key":"10.1016\/j.eplepsyres.2012.06.002_bib0100","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1111\/j.1528-1157.1997.tb01147.x","article-title":"IgA and IgG2 deficiency associated with zonisamide therapy: a case report","volume":"38","author":"Maeoka","year":"1997","journal-title":"Epilepsia"},{"key":"10.1016\/j.eplepsyres.2012.06.002_bib0105","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/j.eplepsyres.2006.06.003","article-title":"Antibodies to voltage-gated potassium and calcium channels in epilepsy","volume":"71","author":"Majoie","year":"2006","journal-title":"Epilepsy Res."},{"key":"10.1016\/j.eplepsyres.2012.06.002_bib0110","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1016\/S0887-8994(01)00325-3","article-title":"Possible induction of systemic lupus erythematosus by zonisamide","volume":"25","author":"Mutoh","year":"2001","journal-title":"Pediatr. Neurol."},{"key":"10.1016\/j.eplepsyres.2012.06.002_bib0115","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/S0920-1211(98)00024-2","article-title":"Elevated levels of interleukin-6 may occur in cerebrospinal fluid from patients with recent epileptic seizures","volume":"31","author":"Peltola","year":"1998","journal-title":"Epilepsy Res."},{"key":"10.1016\/j.eplepsyres.2012.06.002_bib0120","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/S0920-1211(00)00140-6","article-title":"Interleukin-6 and interleukin-1 receptor antagonist in cerebrospinal fluid from patients with recent tonic\u2013clonic seizures","volume":"41","author":"Peltola","year":"2000","journal-title":"Epilepsy Res."},{"key":"10.1016\/j.eplepsyres.2012.06.002_bib0125","doi-asserted-by":"crossref","first-page":"712","DOI":"10.1016\/S0002-9343(00)00617-3","article-title":"Antiphosholipid and antinuclear antibodies in epileptic syndromes and newly onset seizure disorders","volume":"109","author":"Peltola","year":"2000","journal-title":"Am. J. Med."},{"key":"10.1016\/j.eplepsyres.2012.06.002_bib0130","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1212\/WNL.55.1.46","article-title":"Autoantibodies to glutamic acid decarboxylase in patients with therapy-resistant epilepsy","volume":"12","author":"Peltola","year":"2000","journal-title":"Neurology"},{"key":"10.1016\/j.eplepsyres.2012.06.002_bib0135","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1053\/seiz.2001.0575","article-title":"Indicators of inflammation after recent tonic-clonic epileptic seizures correlate with plasma interleukin-6 levels","volume":"11","author":"Peltola","year":"2002","journal-title":"Seizure"},{"key":"10.1016\/j.eplepsyres.2012.06.002_bib0140","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/j.yebeh.2004.11.017","article-title":"Serum IgA, IgG, and IgM concentrations in patients with epilepsy and matched controls: a cohort-based cross-sectional study","volume":"6","author":"Ranua","year":"2005","journal-title":"Epilepsy Behav."},{"key":"10.1016\/j.eplepsyres.2012.06.002_bib0145","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1016\/j.nbd.2007.08.012","article-title":"Innate and adaptive immunity during epileptogenesis and spontaneous seizures: evidence from experimental models and human temporal lobe epilepsy","volume":"29","author":"Ravizza","year":"2008","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.eplepsyres.2012.06.002_bib0150","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1177\/096120330000900715","article-title":"Lamotrigine-induced lupus","volume":"9","author":"Sarzi-Puttini","year":"2000","journal-title":"Lupus"},{"key":"10.1016\/j.eplepsyres.2012.06.002_bib0155","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1016\/S0140-6736(75)90115-4","article-title":"IgA deficiency, epilepsy, and phenytoin treatment","volume":"2","author":"Seager","year":"1975","journal-title":"Lancet"},{"key":"10.1016\/j.eplepsyres.2012.06.002_bib0160","first-page":"273","article-title":"Depression of immune competence by phenytoin and carbamazepine. Studies in vivo and in vitro","volume":"20","author":"Sorrell","year":"1975","journal-title":"Clin. Exp. Immunol."},{"key":"10.1016\/j.eplepsyres.2012.06.002_bib0165","doi-asserted-by":"crossref","first-page":"1233","DOI":"10.1016\/S0140-6736(71)90547-2","article-title":"Depression of immunological function in patients treated with phenytoin sodium (sodium diphenylhydantoin)","volume":"2","author":"Sorrell","year":"1971","journal-title":"Lancet"},{"key":"10.1016\/j.eplepsyres.2012.06.002_bib0170","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1111\/j.1365-3083.1995.tb03555.x","article-title":"A dysbalanced immune system in cryptogenic Lennox-Gastaut syndrome","volume":"41","author":"Van Engelen","year":"1995","journal-title":"Scand. J. Immunol."},{"key":"10.1016\/j.eplepsyres.2012.06.002_bib0175","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/S0002-9343(97)90046-2","article-title":"Prevalence and signification of antinuclear and anticardiolipin antibodies in patients with epilepsy","volume":"10","author":"Verrot","year":"1997","journal-title":"Am. J. Med."},{"key":"10.1016\/j.eplepsyres.2012.06.002_bib0180","doi-asserted-by":"crossref","first-page":"920","DOI":"10.1046\/j.1528-1157.2002.02002.x","article-title":"Increased plasma levels of pro- and anti-inflammatory cytokines in patients with febrile seizures","volume":"43","author":"Virta","year":"2002","journal-title":"Epilepsia"},{"key":"10.1016\/j.eplepsyres.2012.06.002_bib0185","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1002\/path.1877","article-title":"The function of immunoglobulin A in immunity","volume":"208","author":"Woof","year":"2002","journal-title":"J. Pathol."}],"container-title":["Epilepsy Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0920121112001702?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0920121112001702?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,12]],"date-time":"2025-10-12T13:27:23Z","timestamp":1760275643000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0920121112001702"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,1]]},"references-count":37,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2013,1]]}},"alternative-id":["S0920121112001702"],"URL":"https:\/\/doi.org\/10.1016\/j.eplepsyres.2012.06.002","relation":{},"ISSN":["0920-1211"],"issn-type":[{"value":"0920-1211","type":"print"}],"subject":[],"published":{"date-parts":[[2013,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"High concentration of immunoglobulin A is associated with temporal lobe epilepsy","name":"articletitle","label":"Article Title"},{"value":"Epilepsy Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.eplepsyres.2012.06.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2012 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}